Bio

Served as Chief Financial Officer for three U.S. publicly traded companies and one Canadian company. Led Adams Respiratory Therapeutics through its initial public offering, resulting in the most successful healthcare IPO for 2005 according to the Wall Street Journal. Industry expertise includes pharmaceuticals, consumer products, manufacturing, and distribution companies. Over the course of his career, served as Chief Financial Officer for several privately held companies on a full-time and interim basis. Previously served in various capacities at Ernst & Young, LLP, including both audit and mergers & acquisitions practices. A certified public accountant and certified treasury professional.